Showing results (181-190 of 499) with videos related to

Sort By:
Pageof 50
AIDS (London, England)|April 2, 2005
Clonal analyses of HIV quasispecies in patients harbouring plasma genotype with K65R mutation associated with thymidine analogue mutations or L74V substitutionMarc Wirden, Isabelle Malet, Anne Derache, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 27, 2010
Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapyAna Canestri, François-Xavier Lescure, Stephane Jaureguiberry, et al.
AIDS (London, England)|October 4, 2008
Primary genotypic resistance of HIV-1 to CCR5 antagonists in CCR5 antagonist treatment-naive patientsCathia Soulié, Isabelle Malet, Sidonie Lambert-Niclot, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 7, 2003
Health-related quality of life after 1 year of highly active antiretroviral therapyPatrizia Carrieri, Bruno Spire, Ségolène Duran, et al.
AIDS (London, England)|March 21, 2003
Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patientsRobert P Myers, Yves Benhamou, Françoise Imbert-Bismut, et al.
Plos One|November 20, 2014
Clinical features and risk factors for atazanavir (ATV)-associated urolithiasis: a case-control studyMatthieu Lafaurie, Barbara De Sousa, Diane Ponscarme, et al.
AIDS Research and Human Retroviruses|October 14, 2020
A Comparison of Cell Activation, Exhaustion, and Expression of HIV Coreceptors and Restriction Factors in HIV-1- and HIV-2-Infected NonprogressorsMariama Sadjo Diallo, Assia Samri, Charlotte Charpentier, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 16, 2019
Reaching the Second and Third Joint United Nations Programme on HIV/AIDS 90-90-90 Targets Is Accompanied by a Dramatic Reduction in Primary Human Immunodeficiency Virus (HIV) Infection and in Recent HIV Infections in a Large French Nationwide HIV CohortAdrien Le Guillou, Pascal Pugliese, François Raffi, et al.
The Journal of Antimicrobial Chemotherapy|September 1, 2009
Raltegravir has no residual antiviral activity in vivo against HIV-1 with resistance-associated mutations to this drugMarc Wirden, Anne Simon, Luminita Schneider, et al.
AIDS (London, England)|November 18, 2011
Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatmentJacqueline Capeau, Vincent Bouteloup, Christine Katlama, et al.
Pageof 50